Effects of milk and milk products consumption on cancer: A review

Comprehensive Reviews in Food Science and Food Safety

Volumn 12, Issue 3, 2013, Pages 249-264

  Davoodi, H ^a   Esmaeili, S ^b   Mortazavian, A M ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CARDIO-VASCULAR DISEASE RISK FACTORS; DAIRY INDUSTRY; HEALTH BENEFITS; HUMAN NUTRITION; METABOLIC SYNDROMES; MILK PRODUCTS; TYPE-2 DIABETES;

DAIRIES; DAIRY PRODUCTS; NUTRITION;

DISEASES;

EID: 84876103020     PISSN: None     EISSN: 15414337     Source Type: Journal    
DOI: 10.1111/1541-4337.12011     Document Type: Article

References (271)

1. 3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res 71:413-23.
2. Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF, Hayes RB. 2007. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16:2623-30.
3. Ahonen MH, Zhuang YH, Aine R, Ylikomi T, Tuohimaa P. 2000. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 86:40-6.
4. Aihua AL. 2009. Advance on safety evaluation of carrageenan. Zhongguo Zhong Yao Za Zhi 34(5):512-4.
5. Alvarez-León EE, Román-Vinas B, Serra-Majem L. 2006. Dairy products and health: a review of the epidemiological evidence. Br J Nutr 96:S94-9.
6. Aso Y, Akazan H. 1992. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group.Urol Intl 49:125-9.
7. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. 1995. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 27:104-9.
8. Aune D, Lau R, Chan D, Vieira R, Greenwood D, Kampman E, Norat T. 2012. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol 23:37-45.
9. Bal dit Sollier C, Drouet L, Pignaud G, Chevallier C, Caen J, Fiat AM, Izquierdo C, Jolles P. 1996. Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. Thromb Res 81:427-37.
10. Beheshtipour H, Mortazavian AM, Haratian P, Darani KK. 2012. Effects of Chlorella vulgaris and Spirulina platensis addition on the viability of probiotic bacteria in yogurt and its biochemical properties. Eur J Food Res Technol, DOI: 10.1007/s00217-012-1798-4.
11. Belitz H, Grosch W, Schieberle P. 2004. Food chemistry. Berlin, Germany: Springer.
12. Belobrajdic DP, McIntosh GH, Owens JA. 2003. Whey proteins protect more than red meat against azoxymethane-induced ACF in Wistar rats. Cancer Lett 198:43-51.
13. Bhandari SD, Schmidt RH, Rodrick GE. 2005. Hazards resulting from environmental, industrial, and agricultural contaminants. In: Food safety handbook. Hoboken, N.J.: John Wiley & Sons, Inc. p 291-321.
14. Bidoli E, La Vecchia C, Talamini R, Negri E, Parpinel M, Conti E, Montella M, Carbone A, Franceschi S. 2001. Micronutrients and ovarian cancer: a case-control study in Italy. Ann oncol 12:1589-93.
15. Biebinger R, Hurrell R, Ottaway P. 2008. Vitamin and mineral fortification of foods. In: Ottaway PB, editor. Food fortification and supplementation: technological, safety and regulatory aspects. Boca Raton, Fla.: CRC Press. p 27-40.
16. Bingham SA, Day N. 2006. Commentary: fat and breast cancer: time to re-evaluate both methods and results? Intl J Epidemiol 35:1022-4.
17. Biström M, Nordström K. 2002. Identification of key success factors of functional dairy foods product development. Trends Food Sci Technol 13:372-9.
18. Blumenfeld AJ, Fleshner N, Casselman B, Trachtenberg J. 2000. Nutritional aspects of prostate cancer: a review. Can J Urol 7:927-35; discussion 36.
19. Blutt SE, McDonnell TJ, Polek TC, Weigel NL. 2000. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 141:10-7.
20. Bodner-Montville J, Ahuja JKC, Ingwersen LA, Haggerty ES, Enns CW, Perloff BP. 2006. USDA food and nutrient database for dietary studies: released on the web. J Food Compos Anal 19:S100-7.
21. Boeing H. 1991. Epidemiological research in stomach cancer: progress over the last ten years. J Cancer Res Clin Oncol 117:133-43.
22. Boeneke C, Aryana K. 2007. Effect of folic acid fortification on the characteristics of yogurt. Milchwissenschaft 62:192-5.
23. Bösinger S, Luf W, Brandl E. 1993. Oxysterols: their occurrence and biological effects. Intl Dairy J 3:1-33.
24. Bounous G. 2000. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res 20:4785-92.
25. 3. Endocr Rev 6:491-511.
26. Burns A, Rowland I. 2000. Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol 1:13-24.
27. Cadogan J, Eastell R, Jones N, Barker ME. 1997. Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ 315:1255-60.
28. 1. Nat Genet 30:181-4.
29. Cathey C, Huang Z, Sarr A, Clement B, Phillips T. 1994. Development and evaluation of a minicolumn assay for the detection of aflatoxin M1 in milk. J Dairy Sci 77:1223-31.
30. Chan AT, Giovannucci EL. 2010. Primary prevention of colorectal cancer. Gastroenterology 138:2029-43.
31. Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, Virtamo J. 2000. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 11:859-67.
32. Chan JM, Stampfer MJ, Giovannucci EL. 1998. What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol 8(4):263-73.
33. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. 2010. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121:469-77.
34. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E. 2004a. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96:1015-22.
35. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Miller AB, Pietinen P, Potter JD, Rohan TE, Terry P, Toniolo P, Virtanen MJ, Willett WC, Wolk A, Wu K, Yaun SS, Zeleniuch-Jacquotte A, Hunter DJ. 2004b. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96:1015-22.
36. Cho E, Spiegelman D, Hunter DJ, Chen WY, Stampfer MJ, Colditz GA, Willett WC. 2003. Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst 95:1079-85.
37. Cho SS. 2010. Handbook of prebiotics and probiotics ingredients: health benefits and food applications. Boca Raton, Fla.: CRC.
38. Commane D, Hughes R, Shortt C, Rowland I. 2005. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res/Fundam Mol Mech Mutagen 591:276-89.
39. Cox B, Sneyd MJ. 2011. School milk and risk of colorectal cancer: a national case-control study. Am J Epidemiol 173:394-403.
40. Cramer DW, Xu H, Sahi T. 1994. Adult hypolactasia, milk consumption, and age-specific fertility. Am J Epidemiol 139:282-9.
41. Cruz AG, Cadena RS, Walter EHM, Mortazavian AM, Granato D, Faria JAF, Bolini H. 2010. Sensory analysis: relevance for prebiotic, probiotic, and synbiotic product development. Compr Rev Food Sci Food Saf 9:358-73.
42. Cui Y, Rohan TE. 2006. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 15:1427-37.
43. de Moreno de LeBlanc A, Perdigón G. 2010. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc 69:421-8.
44. Dong JY, Zhang L, He K, Qin LQ. 2011. Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies. Breast Cancer Res Treat 127:23-31.
45. Donia M, Abou-Arab A, Enb A, El-Senaity M, Abd-Rabou N. 2010. Chemical composition of raw milk and the accumulation of pesticide residues in milk products. Glob Vet 4:6-14.
46. Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L. 1996. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr 64:850-5.
47. Duarte D, Nicolau A, Teixeira J, Rodrigues L. 2011. The effect of bovine milk lactoferrin on human breast cancer cell lines. J Dairy Sci 94:66-76.
48. European Food Safety Authority (EFSA). 2010. Scientific Opinion on the re-evaluation of Brilliant Blue FCF (E 133) as a food additive. EFSA Panel on Food Additives and Nutrient Sources added to Food. EFSA J 8 (11): 1853; 1-36.
49. Eliassen LT, Berge G, Sveinbjornsson B, Svendsen JS, Vorland LH, Rekdal O. 2002. Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res 22:2703-10.
50. Elwood PC, Givens DI, Beswick AD, Fehily AM, Pickering JE, Gallacher J. 2008. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr 27:723S-34S.
51. Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, Willett WC, Hankinson SE. 2004. A prospective study of dietary lactose and ovarian cancer. Intl J Cancer 110:271-7.
52. Falck Jr. F, Ricci Jr. A, Wolff MS, Godbold J, Deckers P. 1992. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-6.
53. Farlow DW, Xu X, Veenstra TD. 2009. Quantitative measurement of endogenous estrogen metabolites, risk-factors for development of breast cancer, in commercial milk products by LC-MS/MS. Chromatogr B Anal Technol Biomed Life Sci 877(13):1327-34.
54. Fedirko V, Bostick RM, Flanders WD, Long Q, Sidelnikov E, Shaukat A, Daniel CR, Rutherford RE, Woodard JJ. 2009. Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 18:2933-41.
55. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Intl J Cancer 127:2893-917.
56. Fischer WJ, Schilter B, Tritscher AM, Stadler RH. 2011. Contaminants of milk and dairy products. In: Contamination resulting from farm and dairy practices: encyclopedia of dairy sciences. 2nd ed. San Diego: Academic Press. p 887-97.
57. Fleshner N, Bagnell PS, Klotz L, Venkateswaran V. 2004. Dietary fat and prostate cancer. J Urol 171:S19-24.
58. Fonden R, Saarela M, Matto J, Mattila-Sandholm T. 2003. Lactic acid bacteria (LAB) in functional dairy products. Funct Dairy Prod 1:244-57.
59. Forman D. 1989. Are nitrates a significant risk factor in human cancer? Cancer Surv 8(2):443-58.
60. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, Reichrath J. 2003. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164:239-46.
61. Fuquay JW, Fox PF. 2011. Encyclopedia of dairy sciences. 2nd ed., vol. 1. U.K.: Academic Press. p 3-60.
62. Galvano F, Galofaro V, Galvano G. 1996. Occurrence and stability of aflatoxin M1 in milk and milk products: a worldwide review. J Food Protect 59(10):1079-90.
63. Gangadharan D, Nampoothiri KM. 2011. Folate production using Lactococcus lactis ssp cremoris with implications for fortification of skim milk and fruit juices. LWT-Food Sci Technol 44:1859-64.
64. Ganmaa D, Li XM, Wang J, Qin LQ, Wang PY, Sato A. 2002. Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Intl J Cancer 98:262-7.
65. Ganmaa D, Qin LQ, Wang PY, Tezuka H, Teramoto S, Sato A. 2004. A two-generation reproduction study to assess the effects of cows' milk on reproductive development in male and female rats. Fertil Steril 82:1106-14.
66. Ganmaa D, Sato A. 2005. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Med Hypotheses 65:1028-37.
67. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. 1996. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118-26.
68. Gao X, LaValley MP, Tucker KL. 2005. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97:1768-77.
69. Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Arslan A, Beeson WL, Buring JE, Fraser GE, Freudenheim JL, Goldbohm RA. 2006. Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 15:364-72.
70. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401-12.
71. Giovannucci E. 1998. Dietary influences of 1, 25 (OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Cause Control 9:567-82.
72. Giovannucci E. 2005. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Cause Control 16:83-95.
73. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC. 2006. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-9.
74. Giovannucci E, Rimm EB, Wolk A, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. 1998. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58:442-7.
75. Givens D, Morgan R, Elwood P. 2008. Relationship between milk consumption and prostate cancer: a short review. Nutr Bull 33:279-86.
76. Goeptar AR, Koeman JH, van Boekel MAJS, Alink GM. 1997. Impact of digestion on the antimutagenic activity of the milk protein casein. Nutr Res 17:1363-79.
77. Gonzalez CA, Riboli E. 2010. Diet and cancer prevention: contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer 46:2555-62.
78. Goodman MT, Wu AH, Tung KH, McDuffie K, Kolonel LN, Nomura AMY, Terada K, Wilkens LR, Murphy S, Hankin JH. 2002. Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 156:148-57.
79. Govers M, van der Meet R. 1993. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 34:365-70.
80. Grant WB. 2003. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 371-8.
81. Grant WB. 2007. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Intl J Cancer 120:1123-8.
82. Greenlee RT, Murray T, Bolden S, Wingo PA. 2000. Cancer statistics, 2000. CA-Cancer J Clin 50:7-33.
83. Guardiola F, Codony R, Addis P, Rafecas M, Boatella J. 1996. Biological effects of oxysterols: current status. Food Chem Toxicol 34:193-211.
84. Gyenis B, Szigeti J, Molnár N, Varga L. 2005. Use of dried microalgal biomasses to stimulate acid production and growth of Lactobacillus plantarum and Enterococcus faecium in milk. Acta Agraria Kaposváriensis 9:53-9.
85. Hague A, Paraskeva C. 1995. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. Eur J Cancer Prev 4:359-64.
86. Hakkak R, Korourian S, Ronis MJJ, Johnston JM, Badger TM. 2001. Dietary whey protein protects against azoxymethane-induced colon tumors in male rats. Cancer Epidemiol Biomarkers Prev 10:555-8.
87. Hämäläinen E, Adlercreutz H, Puska P, Pietinen P. 1984. Diet and serum sex hormones in healthy men. J Steroid Biochem 20:459-64.
88. Harlow BL, Cramer DW, Geller J, Willett WC, Bell DA, Welch WR. 1991. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol 134:445-53.
89. Heaney RP, McCarron DA, Dawson-Hughes B, Oparil S, Berga SL, Stern JS, Barr SI, Rosen CJ. 1999. Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc 99:1228-33.
90. Heydari S, Mortazavian AM, Ehsani MR, Mohammadifar MA, Ezzatpanah, H. 2011. Biochemical, microbiological and sensory characteristics of probiotic yogurt containing various prebiotic compounds. Ital J Food Sci 23:153-63.
91. Hill P, Wynder EL, Garnes H, Walker A. 1980. Environmental factors, hormone status, and prostatic cancer. Prev Med 9:657-66.
92. Hirayama K, Rafter J. 2000. The role of probiotic bacteria in cancer prevention. Microbes Infect 2:681-6.
93. Hjartåker A, Thoresen M, Engeset D, Lund E. 2010. Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: The Norwegian women and cancer study. Cancer Cause Control 21:1875-85.
94. Holick MF. 2008. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol 3:1548-54.
95. Holmes MD, Pollak MN, Willett WC, Hankinson SE. 2002. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:852-61.
96. Holmes MD, Schisterman EF, Spiegelman D, Hunter DJ, Willett WC. 1999. Re: meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91:1511-2.
97. Holt PR. 2008. New insights into calcium, dairy and colon cancer. World J Gastroenterol 14:4429-33.
98. Holt PR, Atillasoy EO, Gilman J, Guss J, Moss SF, Newmark H, Fan K, Yang K, Lipkin M. 1998. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 280:1074-9.
99. Holt PR, Wolper C, Moss SF, Yang K, Lipkin M. 2001. Comparison of calcium supplementation or low-fat dairy foods on epithelial cell proliferation and differentiation. Nutr Cancer 41:150-5.
100. Hoppe C, Mølgaard C, Michaelsen KF. 2006. Cow's milk and linear growth in industrialized and developing countries. Annu Rev Nutr 26:131-73.
101. Howe G, Burch J, Miller A, Morrison B, Gordon P, Weldon L, Chambers L, Fodor G, Winsor G. 1977. Artificial sweeteners and human bladder cancer. Lancet 310:578-81.
102. Hunter DJ, Kelsey KT. 1993. Pesticide residues and breast cancer: the harvest of a silent spring? J Natl Cancer Inst 85:598-9.
103. Iigo M, Alexander DB, Long N, Xu J, Fukamachi K, Futakuchi M, Takase M, Tsuda H. 2009. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie 91:86-101.
104. Imai H, Werthessen NT, Subramanyam V, Lequesne PW, Soloway AH, Kanisawa M. 1980. Angiotoxicity of oxygenated sterols and possible precursors. Science 207:651-3.
105. Indyk HE, Woollard DC. 2011. Contaminants of milk and dairy products: nitrates and nitrites as contaminants. In: Fuquay JW, editor-in chief. Encyclopedia of dairy sciences. 2nd ed. San Diego: Academic Press. p 906-11.
106. Jankevicius F, Miller S, Ackermann R. 2002. Nutrition and risk of prostate cancer. Urol Intl 68:69-80.
107. JECFA (Joint FAO/WHO Expert Committee on Food Additives). 1970. Toxicological evaluation of some food colours, emulsifiers, stabilizers, anticaking agents, and certain other substances. 13th Report, WHO Food Additives Series 70.36.
108. Jelen P. 2005. In: Shortt C, O'Brien J, editors. Handbook of functional dairy products. Boca Raton, Fla: CRC Press.
109. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. 2004. Cancer statistics, 2004. Cancer J Clin 54:8-29.
110. Jerome L, Shiry L, Leyland-Jones B. 2003. Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions. Endocr Relat Cancer 10:561-78.
111. Jiang F, Bao J, Li P, Nicosia SV, Bai W. 2004. Induction of ovarian cancer cell apoptosis by 1, 25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 279:53213-21.
112. Jones EL, Shingfield KJ, Kohen C, Jones AK, Lupoli B, Grandison AS, Beever DE, Williams CM, Calder PC, Yaqoob P. 2005. Chemical, physical, and sensory properties of dairy products enriched with conjugated linoleic acid. J Dairy Sci 88:2923-37.
113. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34.
114. Kahraman O, Ustunol Z. 2012. Effect of zinc fortification on Cheddar cheese quality. J Dairy Sci 95:2840-7.
115. Karagas MR, Tosteson TD, Greenberg ER, Rothstein RI, Roebuck BD, Herrin M, Ahnen D. 1998. Effects of milk and milk products on rectal mucosal cell proliferation in humans. Cancer Epidemiol Biomarkers Prev 7:757-66.
116. Karimi R, Mortazavian A, Da Cruz A. 2011. Viability of probiotic microorganisms in cheese during production and storage: a review. Dairy Sci Technol 91:283-308.
117. Kato I, Endo K, Yokokura T. 1994. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Intl J Immunopharmacol 16:29-36.
118. Kato I, Tanaka K, Yokokura T. 1999. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-[gamma] by mouse splenocytes. Intl J Immunopharmaco 21:121-31.
119. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. 1981. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 304:994-8.
120. 3 fortification and quantification in processed dairy products. Intl Dairy J 17:753-9.
121. Kelley NS, Hubbard NE, Erickson KL. 2007. Conjugated linoleic acid isomers and cancer. J Nutr 137:2599-607.
122. Kennedy JF, Bandaiphet C. 2004. Carbohydrate polymers: functional dairy products. In: Mattila-Sandholm T, Saarela M, editors. Cambridge, U.K.: Woodhead Publishing Limited. p 395.
123. Kent K, Harper W, Bomser J. 2003. Effect of whey protein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epithelial cells. Toxicol In Vitro 17:27-33.
124. Keszei AP, Schouten LJ, Goldbohm RA, van den Brandt PA. 2010. Dairy intake and the risk of bladder cancer in the Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol 171:436-46.
125. Klein EA. 2005. Chemoprevention of prostate cancer. Crit Rev Oncol Hematol 54:1-10.
126. Knasmüller S, Steinkellner H, Hirschl AM, Rabot S, Nobis EC, Kassie F. 2001. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat Res Fundam Mol Mech Mutagen 480:129-38.
127. Knekt P, Järvinen R, Seppänen R, Pukkala E, Aromaa A. 1996. Intake of dairy products and the risk of breast cancer. Br J Cancer 73:687-91.
128. Koralek DO, Bertone-Johnson ER, Leitzmann MF, Sturgeon SR, Lacey Jr. JV, Schairer C, Schatzkin A. 2006. Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer 56:22-30.
129. Kumar A, Singh NK, Sinha PR, Kumar R. 2010b. Intervention of Acidophilus casei dahi and wheat bran against molecular alteration in colon carcinogenesis. Mol Biol Rep 37:621-7.
130. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, Kumar P, Poddar D, Aggarwal P, Henry C. 2010a. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr 61:473-96.
131. 1-induced liver carcinogenesis in rats. Brit J Nutr 107(7):1006-16.
132. Kumar M, Verma V, Nagpal R, Kumar A, Gautam SK, Behare PV, Grover CR, Aggarwal PK. 2011. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB-induced hepatocellular carcinoma. Gene 490:54-9.
133. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane S. 2008. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev 17:930-7.
134. Kushi LH, Byers T, Doyle C, Bandera EV, McCullough M, Gansler T, Andrews KS, Thun MJ. 2006. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. Cancer J Clin 56:254-81.
135. Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich DA, Sellers TA. 1999. Prospective study of diet and ovarian cancer. Am J Epidemiol 149:21-31.
136. La Vecchia C, Negri E, D'Avanzo B, Boyle P, Franceschi S. 1991. Dietary indicators of oral and pharyngeal cancer. Intl J Epidemiol 20:39-44.
137. Laakkonen A, Pukkala E. 2008. Cancer incidence among Finnish farmers, 1995-2005. Scand J Work Environ Health 34:73-9.
138. Laffineur E, Genetet N, Leonil J. 1996. Immunomodulatory activity of beta-casein permeate medium fermented by lactic acid bacteria. J Dairy Sci 79:2112-20.
139. Lampe JW. 2011. Dairy products and cancer. J Am Coll Nutr 30:464S-70S.
140. Lamprecht SA, Lipkin M. 2001. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci 952:73-87.
141. Larsson SC, Andersson SO, Johansson JE, Wolk A. 2008. Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men. Am J Clin Nutr 88:1083-7.
142. Larsson SC, Bergkvist L, Wolk A. 2004. Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 80:1353-7.
143. Larsson SC, Bergkvist L, Wolk A. 2005. High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish mammography cohort. Am J Clin Nutr 82:894-900.
144. Larsson SC, Bergkvist L, Wolk A. 2006a. Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study. Am J Clin Nutr 84:1171-6.
145. Larsson SC, Orsini N, Wolk A. 2006a. Milk, milk products and lactose intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Intl J Cancer 118:431-41.
146. Lee MM, Lin SS. 2000. Dietary fat and breast cancer. Annu Rev Nutr 20:221-48.
147. Lefkowitz ES, Garland CF. 1994. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Intl J Epidemiol 23:1133-6.
148. Li F, An S, Zhou Y, Liang Z, Jiao Z, Jing Y, Wan P, Shi X, Tan W. 2011. Milk and dairy consumption and risk of bladder cancer: a meta-analysis. Urology 78:1298-305.
149. Li H, Stampfer MJ, Hollis JBW, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J. 2007. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 4(3):e103.
150. Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH. 1995. Protection of conjugated linoleic acids against 2-amino-3- methylimidazo[4, 5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 16:3037-43.
151. Lim BK, Mahendran R, Lee YK, Bay BH. 2002. Chemopreventive effect of Lactobacilus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the Mouse. Cancer Sci 93:36-41.
152. Linseisen J, Wolfram G. 1998. Origin, metabolism, and adverse health effects of cholesterol oxidation products. Lipid/Fett 100:211-8.
153. Llor X, Jacoby RF, Teng BB, Davidson NO, Sitrin MD, Brasitus TA. 1991. K-ras mutations in 1, 2-dimethylhydrazine-induced colonic tumors: effects of supplemental dietary calcium and vitamin D deficiency. Cancer Res 51:4305-9.
154. Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L. 1999. Inhibition of prostate cancer metastasis in vivo: a comparison of 1, 25-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol Biomarkers Prev 8:241-8.
155. Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M. 2001. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). J Natl Cancer Inst 93:1852-7.
156. MacDonald RS, Thornton WH, Marshall RT. 1994. A cell culture model to identify biologically active peptides generated by bacterial hydrolysis of casein. J Dairy Sci 77:1167-75.
157. Mao QQ, Dai Y, Lin YW, Qin J, Xie LP, Zheng XY. 2011. Milk consumption and bladder cancer risk: A meta-analysis of published epidemiological studies. Nutr Cancer 63:1263-71.
158. Marmot M, Atinmo T, Byers T, Chen J, Hirohata T, Jackson A, James W, Kolonel L, Kumanyika S, Leitzmann C. 2007. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR. p 46.
159. Marshall NK. 2004. Therapeutic applications of whey protein. Altern Med Rev 9:136-56.
160. Matar C, Amiot J, Savoie L, Goulet J. 1996. The effect of milk fermentation by Lactobacillus helveticus on the release of peptides during in vitro digestion. J Dairy Sci 79:971-9.
161. Matsuzaki T. 1998. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Intl J Food Microbiol 41:133-40.
162. McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL. 2004. Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev 13:1480-4.
163. McCarron DA, Heaney RP. 2004. Estimated healthcare savings associated with adequate dairy food intake. Am J Hypertens 17:88-97.
164. McConkey DJ, Orrenius S. 1997. The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun 239:357-66.
165. McCullough ML, Rodriguez C, Diver WR, Feigelson HS, Stevens VL, Thun MJ, Calle EE. 2005. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 14:2898-904.
166. McIntosh GH, Le Leu RK. 2001. The influence of dietary proteins on colon cancer risk. Nutr Res 21:1053-66.
167. McIntosh GH, Regester GO, Le Leu RK, Royle PJ, Smithers GW. 1995. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 125:809-16.
168. McIntosh GH, Royle PJ, Le Leu RK, Regester GO, Johnson MA, Grinsted RL, Kenward RS, Smithers GW. 1998. Whey proteins as functional food ingredients? Intl Dairy J 8:425-34.
169. Meisel H, FitzGerald R. 2003. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des 9:1289-96.
170. Micke P, Beeh K, Schlaak J, Buhl R. 2001. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest 31:171-8.
171. Miller GD, Jarvis JK, McBean LD. 2007. Handbook of dairy foods and nutrition. Boca Raton, Fla.: CRC. p 1.
172. Mizoue T, Kimura Y, Toyomura K, Nagano J, Kono S, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Imaizumi N. 2008. Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka colorectal cancer study. Cancer Epidemiol Biomarkers Prev 17:2800-7.
173. Mohamadi R, Mortazavian AM. 2010. Technological aspects of prebiotics in probiotic fermented milks. Food Rev Intl 27:192-212.
174. Mohammadi R, Mortazavian A. 2011. Review article: technological aspects of prebiotics in probiotic fermented milks. Food Rev Intl 27:192-212.
175. Mohammadi R, Mortazavian AM, Khosrokhavar R, da Cruz AG. 2011. Probiotic ice cream: viability of probiotic bacteria and sensory properties. Ann Microbiol 61:411-24.
176. Mohammadi R, Sohrabvandi S, Mortazavian AM. 2012. The starter culture characteristics of probiotic microorganisms in fermented milks. Eng Life Sci 12(4):399-409.
177. Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA. 2005. Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 94:165-70.
178. Moorman PG, Terry PD. 2004. Consumption of dairy products and the risk of breast cancer: a review of the literature. Am J Clin Nutr 80:5-14.
179. Moss MO. 2002. Risk assessment for aflatoxins in foodstuffs. Intl Biodeterior Biodegrd 50:137-42.
180. Newmark HL, Wargovich MJ, Bruce WR. 1984. Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst 72:1323-5.
181. Norat T, Riboli E. 2003. Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr 57:1-17.
182. Norgauer C. 2005. Ecological study of the role of highly processed milk, meat and vegetable oil in prostate cancer causation. Boca Raton, Fla: Universal-Publishers.
183. Nwosu V, Carpten J, Trent JM, Sheridan R. 2001. Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet 10:2313-8.
184. O'Brien N, O'Callaghan Y, Lyons N, Woods J. 2000. Biological effects of dietary cholesterol oxidation products. Irish J Agric Food Res 265-73.
185. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, Kitamura T, Kawabe K, Kotake T, Kuroda M. 2002. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Intl 68:273-80.
186. Outwater J, Nicholson A, Barnard N. 1997. Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis. Med Hypotheses 48:453-61.
187. Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A. 2009. Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intl Med 169:391-401.
188. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA-Cancer J Clin 55:74-108.
189. Parodi P. 1999. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci 82:1339-49.
190. Parodi P. 2007. A role for milk proteins and their peptides in cancer prevention. Curr Pharm Des 13:813-28.
191. Parodi P. 2008. Milk lipids: their role as potential anti-cancer agents. Sci des Aliments 28:44-52.
192. Parodi PW. 1997. Cows' milk fat components as potential anticarcinogenic agents. J Nutr 127:1055-60.
193. Parodi PW. 1998. A role for milk proteins in cancer prevention. Aust J Dairy Technol 53:37-47.
194. Parodi PW. 2001. Cow's milk components with anti-cancer potential. Aust J Dairy Technol 56:65-73.
195. Parodi PW. 2005. Dairy product consumption and the risk of breast cancer. J Am Coll Nutr 24:556S-68S.
196. Parodi PW. 2009. Dairy product consumption and the risk of prostate cancer. Intl Dairy J 19:551-65.
197. Parodi PW. 2012. Impact of cows' milk estrogen on cancer risk. Intl Dairy J 22:3-14.
198. Pihlanto-Leppälä A, Rokka T, Korhonen H. 1998. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Intl Dairy J 8:325-31.
199. Pollak MN, Schernhammer ES, Hankinson SE. 2004. Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-18.
200. Prandini A, Tansini G, Sigolo S, Filippi L, Laporta M, Piva G. 2009. On the occurrence of aflatoxin M1 in milk and dairy products. Food Chem Toxicol 47:984-91.
201. Prinz-Langenohl R, Fohr I, Pietrzik K. 2001. Beneficial role for folate in the prevention of colorectal and breast cancer. Eur J Nutr 40:98-105.
202. Prosser CG, Fleet IR, Corps AN. 1989. Increased secretion of insulin-like growth factor I into milk of cows treated with recombinantly derived bovine growth hormone. J Dairy Res 56:17-26.
203. Qin L, Xu J, Wang P, Tong J, Hoshi K. 2007. Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Asia Pac J Clin Nutr 16:467-76.
204. Qin LQ, Wang PY, Kaneko T, Hoshi K, Sato A. 2004a. Estrogen: one of the risk factors in milk for prostate cancer. Med Hypotheses 62:133-42.
205. Qin LQ, Xu JY, Wang PY, Ganmaa D, Li J, Wang J, Kaneko T, Hoshi K, Shirai T, Sato A. 2004b. Low-fat milk promotes the development of 7, 12-dimethylbenzo anthracene (DMBA)-induced mammary tumors in rats. Intl J Cancer 110:491-6.
206. Radosavljević V, Janković S, Marinković J, Djokić M. 2003. Fluid intake and bladder cancer. A case control study. Neoplasma 50:234-8.
207. Ramasamy I. 2006. Recent advances in physiological calcium homeostasis. Clin Chem Lab Med 44:237-73.
208. Rayes AAH, El-Naggar SMM, Mehanna NS. 2008. The effect of natural fermented milk in the protection of liver from cancer. Nutr Food Sci 38:578-92.
209. RDAs NRCSotTEot, Allowances NRC CoD. 1989. Recommended dietary allowances. Washington DC: National Academies Press.
210. Reichardt JK, Woo SL. 1991. Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci USA 88:2633-7.
211. Reichel H, Koeffler HP, Norman AW. 1989. The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-91.
212. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. 2004. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. The Lancet 363:1346-53.
213. Rodland KD. 2004. The role of the calcium-sensing receptor in cancer. Cell Calcium 35:291-5.
214. Rodrigues L, Teixeira J, Schmitt F, Paulsson M, Månsson HL. 2008. Lactoferrin and cancer disease prevention. Crit Rev Food Sci 49:203-17.
215. Rodríguez-Alcalá LM, Fontecha J. 2007. Hot topic: fatty acid and conjugated linoleic acid (CLA) isomer composition of commercial CLA-fortified dairy products: evaluation after processing and storage. J Dairy Sci 90:2083-90.
216. Rökman A, Ikonen T, Seppälä EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP. 2002. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70:1299-304.
217. Ross RK, Henderson BE. 1994. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 86:252-5.
218. Saito H, Takase M, Tamura Y, Shimamura S, Tomita M. 1994. Physicochemical and antibacterial properties of lactoferrin and its hydrolysate produced by heat treatment at acidic pH. Adv Exp Med Biol 357:219-26.
219. Sandrine G, Boeriu CG, Wichers HJ. 2001. Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. J Agric Food Chem 49:295-302.
220. Saunders D, Christensen C, Williams J, Wappler N, Lawrence W, Malone J, Malviya V, Deppe G. 1995. Inhibition of breast and ovarian carcinoma cell growth by 1, 25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone. Anticancer Drugs 6:562-9.
221. Saunders DE, Christensen C, Lawrence WD, Malviya VK, Malone JM, Williams JR, Deppe G. 1992. Receptors for 1, 25-dihydroxyvitamin D3 in gynecologic neoplasms. Gynecol Oncol 44:131-6.
222. Saxelin M, Korpela R, Mäyrä-Mäkinen A, Mattila-Sandholm T, Saarela M. 2003. Introduction: classifying functional dairy products. In: Mattila-Sandholm T, Saarela M, editors. Functional dairy products. Cambridge, U.K.: CRC Press-Woodhead Publishing. p 1-16.
223. stseries), opinion expressed in 1975. No. 17.
224. th series), opinion expressed in 1983. No. 47-61.
225. Schmitz-Drager BJ, Eichholzer M, Beiche B, Ebert T. 2001. Nutrition and prostate cancer. Urol Intl 67:1-11.
226. Schrezenmeir J, de Vrese M. 2001. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 73:361S-4S.
227. Schulman C, Ekane S, Zlotta A. 2001. Nutrition and prostate cancer: evidence or suspicion? Urology 58:318-34.
228. Schuurman AG, van den Brandt PA, Dorant E, Brants HAM, Goldbohm A R. 1999. Association of energy and fat intake with prostate carcinoma risk. Cancer 86:1019-27.
229. Scudamore KA. 1998. In: Watson DH, editor. Natural toxicants in food. Sheffield: Sheffield Academic Press Ltd.
230. Seppo L, Jauhiainen T, Poussa T, Korpela R. 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77:326-30.
231. Sergeev IN. 2005. Calcium signaling in cancer and vitamin D. J Steroid Biochem Mol Biol 97:145-51.
232. Sevanian A, Peterson A. 1986. The cytotoxic and mutagenic properties of cholesterol oxidation products. Food Chem Toxicol 24:1103-10.
233. Sieber R. 2005. Oxidised cholesterol in milk and dairy products. Intl Dairy J 15:191-206.
234. Sieri S, Krogh V, Ferrari P, Berrino F, Pala V, Thiébaut ACM, Tjønneland A, Olsen A, Overvad K, Jakobsen MU. 2008. Dietary fat and breast cancer risk in the European prospective investigation into cancer and nutrition. Am J Clin Nutr 88:1304-12.
235. Singh G, Arora S, Sharma GS, Sindhu JS, Kansal VK, Sangwan RB. 2007. Heat stability and calcium bioavailability of calcium-fortified milk. LWT-Food Sci Technol 40:625-31.
236. Slattery ML, Benson J, Berry TD, Duncan D, Edwards SL, Caan BJ, Potter JD. 1997. Dietary sugar and colon cancer. Cancer Epidemiol Biomarkers Prev 6:677-85.
237. Spanhaak S, Havenaar R, Schaafsma G. 1998. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52:899-907.
238. Sung V, Feldman D. 2000. 1, 25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol 164:133-43.
239. Swartz WJ, Mattison DR. 1988. Galactose inhibition of ovulation in mice. Fertil Steril 49:522-6.
240. Terry P, Suzuki R, Hu FB, Wolk A. 2001. A prospective study of major dietary patterns and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 10:1281-5.
241. Thiébaut ACM, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A. 2007. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP diet and health study cohort. J Natl Cancer Inst 99:451-62.
242. Thirabunyanon M, Boonprasom P, Niamsup P. 2009. Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnol Lett 31:571-6.
243. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman Jr. CA. 2003. The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215-24.
244. Tomita K, Akaza H, Nomoto K, Yokokura T, Matsushima H, Homma Y, Aso Y. 1994. Influence of Lactobacillus casei on rat bladder carcinogenesis. Jpn J Urol 85:655-63.
245. Toriola AT, Surcel HM, Calypse A, Grankvist K, Luostarinen T, Lukanova A, Pukkala E, Lehtinen M. 2010. Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study. Eur J Cancer 46:2799-805.
246. Tsuda H, Kozu T, Iinuma G, Ohashi Y, Saito Y, Saito D, Akasu T, Alexander DB, Futakuchi M, Fukamachi K, Xu J, Kakizoe T, Iigo M. 2010. Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals 23:399-409.
247. Tsuda H, Sekine K, Ki F, Iigo M. 2002. Cancer prevention by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem Cell Biol 80:131-6.
248. Tsuda H, Sekine K, Ushida Y, Kuhara T, Takasuka N, Iigo M, Han BS, Moore MA. 2000. Milk and dairy products in cancer prevention: focus on bovine lactoferrin. Mutat Res 462:227-33.
249. Turner P, Mendy M, Whittle H, Fortuin M, Hall A, Wild C. 2000. Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Intl Health 5:837-41.
250. van Boekel M. 1998. Effect of heating on Maillard reactions in milk. Food Chem 62:403-14.
251. van Loon AJM, Botterweck AAM, Goldbohm RA, Brants HAM, van den Brandt PA. 1997. Nitrate intake and gastric cancer risk: results from the Netherlands cohort study. Cancer Lett 114:259-61.
252. Varga L, Szigeti J, Kovács R, Földes T, Buti S. 2002. Influence of a Spirulina platensis biomass on the microflora of fermented ABT milks during storage. J Dairy Sci 85:1031-8.
253. Vecchia C, Negri E. 1996. Nutrition and bladder cancer. Cancer Cause Control 7:95-100.
254. Veierød MB, Laake P, Thelle DS. 1997. Dietary fat intake and risk of prostate cancer: a prospective study of 25, 708 Norwegian men. Intl J Cancer 73:634-8.
255. Vieth R. 2001. Vitamin D nutrition and its potential health benefits for bone, cancer and other conditions. J Nutr Environ Med 11:275-91.
256. Villena-Heinsen C, Meyberg R, Axt-Fliedner R, Reitnauer K, Reichrath J, Friedrich M. 2002. Immunohistochemical analysis of 1, 25-dihydroxyvitamin-D3 receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res 22:2261-7.
257. Vyas HK, Tong PS. 2004. Impact of source and level of calcium fortification on the heat stability of reconstituted skim milk powder. J Dairy Sci 87:1177-80.
258. Wakabayashi H, Yamauchi K, Takase M. 2006. Lactoferrin research, technology and applications. Intl Dairy J 16:1241-51.
259. Walzem R, Dillard C, German J. 2002. Whey components: millennia of evolution create functionalities for mammalian nutrition: what we know and what we may be overlooking. Crit Rev Food Sci Nutr 42:353-75.
260. Ward MH, Kilfoy BA, Weyer PJ, Anderson KE, Folsom AR, Cerhan JR. 2010. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 21:389-95.
261. Ward P, Paz E, Conneely O. 2005. Lactoferrin. Cell Mol Life Sci 62:2540-8.
262. Watanabe K, Reddy BS, Wong CQ, Weisburger JH. 1978. Effect of dietary undegraded carrageenan on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea. Cancer Res 38:4427-30.
263. Welsch CW. 1992. Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res 52:2040s-8s.
264. Wollowski I, Rechkemmer G, Pool-Zobel BL. 2001. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73:451S-55S.
265. Wu AH, Pike MC, Stram DO. 1999. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91:529-34.
266. Yager JD, Davidson NE. 2006. Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-82.
267. Yorifuji T, Tsuda T, Doi H, Grandjean P. 2011. Cancer excess after arsenic exposure from contaminated milk powder. Environ Health Prev Med 16:164-70.
268. Yorifuji T, Tsuda T, Grandjean P. 2010. Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder. J Natl Cancer Inst 102:360-1.
269. Yu H, Rohan T. 2000. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472-89.
270. Zhang D, Mahoney AW. 1989. Effect of iron fortification on quality of Cheddar cheese. J Dairy Sci 72:322-32.
271. Zhang D, Mahoney AW. 1991. Iron fortification of process Cheddar cheese. J Dairy Sci 74:353-8.